Health Jun 07

A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. Photo by Brian Snyder/REUTERS
Watch 6:00
Why the FDA approved a controversial Alzheimer’s drug

The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said…